The Art of Effective R&D Transformation
Productive R&D is the lifeblood of leading pharmaceutical and biotech companies, and with increased pressure to create meaningful new medicines, R&D effectiveness can always be improved. In our recent webinar, John Rountree, Managing Partner at Novasecta, was joined by a panel of pharma company R&D Heads, who shared their experiences on how they have been […]
Reimagine Pharma’s Commercial Model
Digitisation has already impacted, and will continue to transform, how pharma’s commercial teams interact with healthcare professionals, engage with patients, and evolve their salesforce. The COVID-19 pandemic has accelerated the previously incremental steps of digitisation for commercial teams. During lockdown, it became much more difficult for salespeople to access physicians in person – this has […]
Reimagine Pharma’s Commercial Model
Pharma has long been evolving its commercial model, but the pandemic has highlighted the need to accelerate this process. And for the emerging commercial model to succeed, Pharma and Biotech businesses are going to need to evolve. Remote working, for example, has changed how our industry interacts with its customers and your business will need […]
Make a Lasting Difference Through Cross-Functional Collaboration
Effective cross-functional collaboration is essential for the future of pharma and biotech firms. Nurtured and encouraged correctly, it stimulates creative thinking that can boost the success of your entire firm – which makes implementing it into your company’s processes an absolute must. In this on-demand webinar, Andrew Bell of Novasecta was joined by three leaders […]
Reimagine Medical Affairs
Medical Affairs has traditionally been an under-represented function in pharmaceutical decision-making. Yet more recently leading pharmaceutical companies have started to make much better use of Medical Affairs’ ability to understand and amplify the patient voice, resulting in higher quality R&D and Commercial decision-making. In this webinar, Andrew Bell of Novasecta was joined by Jill Massey […]
Create An Effective Pharma R&D Mindset
Productive R&D is the lifeblood of pharmaceutical companies. But great pharmaceutical R&D requires a mindset that transcends classical management approaches. How can organisations create effective R&D mindsets to ensure they continue to get the most from their internal and external R&D ecosystems? How do they acquire, motivate and manage the multiple sources of internal and […]
AstraZeneca sacrifices revenue with a no-profit Covid-19 vaccine (Daily Mail)
Astrazeneca sacrificed over £21billion of revenues by selling its Covid vaccine at no profit Early in the Covid-19 pandemic, AstraZeneca received substantial praise for agreeing to make the “oxford vaccine” available at cost. However, as countries have struggle to struggled to secure sufficient supply the conversation has soured. Commenting on the situation, Novasecta’s managing partner […]
Oxford vaccine news is very encouraging (CNBC)
In light of the recent news on the Oxford Covid-19 vaccine, John Rountree, was invited on CNBC to discuss the outlook. Discover John’s previous comments on the vaccine here.
Vaccine nationalism could be devastating (CNBC)
“Vaccine nationalism” is turning the search for a Covid-19 cure into an arms race, which will ultimately damage the economy and public health, experts have warned. Despite these warnings, John Rountree is optimistic about vaccine access. John told CNBC, distribution and supply challenges are “much more solvable” than actually finding a vaccine that works and […]
Enrich the R&D pipeline
Challenge A newly established R&D therapeutic area team was tasked with creating attractive commercial opportunities to drive future growth beyond a Pharma company’s core therapeutic area. The new team, which integrated two previously separate teams, required a clear focus to align on how to maximise value creation from its combined portfolio and enrich its future […]